• Keine Ergebnisse gefunden

List of nationally authorised medicinal products

N/A
N/A
Protected

Academic year: 2022

Aktie "List of nationally authorised medicinal products "

Copied!
8
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

30 Churchill Place Canary Wharf London E14 5EU United Kingdom

An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525

Send a question via our website www.ema.europa.eu/contact

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

30 November 2017 EMA/817337/2017

Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: Itraconazole

Procedure no.: PSUSA/00001798/201703

(2)

Product Name

(in authorisation country)

MRP/DCP Authorisation Number

National Authorisation Number

MAH of product in the Member State

Member State where product is authorised Sporanox 10 mg/ml Lösung

zum Einnehmen

UK/H/0158/001 BE190294 JANSSEN-CILAG NV BE

Sporanox 10 mg/ml oral lösning

UK/H/0158/001 12546 JANSSEN-CILAG OY FI

Sporanox 10 mg/ml Lösung zum Einnehmen

UK/H/0158/001 2002016306 JANSSEN-CILAG NV LU

SPORANOX 10 mg/ml Oral Solution.

UK/H/0158/001 PL 00242/0307 JANSSEN-CILAG LIMITED UK

SPORANOX 10 mg/ml solution buvable

UK/H/0158/001 2002016306 JANSSEN-CILAG NV LU

Sporanox 10 mg/ml Lösung zum Einnehmen

UK/H/0158/001 1-22084 JANSSEN-CILAG PHARMA

GMBH

AT

Sporanox 10 mg/ml oral lösning

UK/H/0158/001 13358 JANSSEN-CILAG AB SE

SPORANOX 10 mg/ml oraaliliuos

UK/H/0158/001 12546 JANSSEN-CILAG OY FI

Sempera Liquid 10 mg/ml, Lösung zum Einnehmen

UK/H/0158/001 39682.00.00 JANSSEN-CILAG GMBH DE

SPORANOX 10 mg/ml Oral Solution.

UK/H/0158/001 PA 0748/009/001 JANSSEN-CILAG LIMITED IE

SPORANOX 10 mg/ml solution buvable

UK/H/0158/001 BE 190294 JANSSEN-CILAG NV BE

SPORANOX 10 mg/ml, drank. UK/H/0158/001 BE190294 JANSSEN-CILAG NV BE

Trisporal O.S.-drank 10 mg/ml, drank.

UK/H/0158/001 RVG 21024 JANSSEN-CILAG BV NL

SPORANOX 10 mg/ml soluzione orale

UK/H/0158/001 027808029/M JANSSEN-CILAG SPA IT

(3)

List of nationally authorised medicinal products

EMA/817337/2017 Page 3/8

Product Name

(in authorisation country)

MRP/DCP Authorisation Number

National Authorisation Number

MAH of product in the Member State

Member State where product is authorised SPORANOX 10 mg/ml Solução

Oral

UK/H/0158/001 2588382 JANSSEN FARMACÊUTICA

PORTUGAL, LDA

PT Sporanox 100 mg Hartkapseln not available BE 145905 JANSSEN-CILAG NV BE

Sporanox 100 mg kapsel, hård not available 11191 JANSSEN-CILAG OY FI

SPORANOX 100 mg, gélule not available 334 604-1 JANSSEN-CILAG FR

SPORANOX 100 mg, gélule not available 334 627-1 JANSSEN-CILAG FR

SPORANOX 100 mg, gélule not available 334 603-5 JANSSEN-CILAG FR

SPORANOX 100 mg, gélule not available 334 630-2 JANSSEN-CILAG FR

SPORANOX 100 mg, gélule not available 334 602-9 JANSSEN-CILAG FR

SPORANOX 100 mg, gélule not available 557 937-0 JANSSEN-CILAG FR

Sporanox 100 mg Hartkapseln not available 2008089906 JANSSEN-CILAG NV LU

SPORANOX 100 mg capsule rigide

not available 027808017 JANSSEN-CILAG SPA IT

SIROS Kapseln, 100 mg Hartkapseln

not available 17034.00.00 JANSSEN-CILAG GMBH DE

SPORANOX 100 mg kapsuly not available 26/0194/90-C/S JOHNSON & JOHNSON, S.R.O SK

SPORAL™ 100mg Capsules. not available 018/02401 JANSSEN-CILAG INTERNATIONAL NV

MT

(4)

SPORAL™ 100mg Capsules. not available 018/02401 JANSSEN-CILAG INTERNATIONAL NV

MT

SEMPERA 7 Kapseln, 100 mg Hartkapseln

not available 31042.00.00 JANSSEN-CILAG GMBH DE

Orungal 100 mg kemény kapszula

not available OGYI-T-2172/03 JANSSEN-CILAG KFT. HU

Orungal 100 mg kemény kapszula

not available OGYI-T-2172/02 JANSSEN-CILAG KFT. HU

Orungal 100 mg kemény kapszula

not available OGYI-T-2172/01 JANSSEN-CILAG KFT. HU

Orungal 100 mg capsule not available 4909/2004/02 JANSSEN PHARMACEUTICA NV RO

SPORAL™ 100 mg Capsules not available 12662 JANSSEN-CILAG

INTERNATIONAL NV

CY

Trisporal 100 mg capsules, hard.

not available RVG 13224 JANSSEN-CILAG BV NL

SPORANOX 100 mg, gélules not available 2008089906 JANSSEN-CILAG NV LU

Sporanox, kapsler not available 13777 JANSSEN-CILAG A/S DK

SPORANOX 10 mg/ml, solution buvable

not available 345 020-6 JANSSEN-CILAG FR

Sporanox 100 mg Capsules not available PL 00242/0142 JANSSEN-CILAG LIMITED UK

SPORANOX 10 mg/ml perorální roztok

not available 26/1097/97-C JANSSEN-CILAG S.R.O CZ

SPORANOX 100 mg capsules, hard

not available BE 145905 JANSSEN-CILAG NV BE

(5)

List of nationally authorised medicinal products

EMA/817337/2017 Page 5/8

Product Name

(in authorisation country)

MRP/DCP Authorisation Number

National Authorisation Number

MAH of product in the Member State

Member State where product is authorised

SPORANOX 100 mg, gélules not available BE 145905 JANSSEN-CILAG NV BE

ORUNGAL, 100 mg, kapsułki not available R/0043 JANSSEN-CILAG INTERNATIONAL NV

PL

Sporanox 100 mg kapsel, hard not available 8158 JANSSEN-CILAG A/S NO

Trisporal IV 10 mg/ml concentraat en oplosmiddel voor oplossing voor infusie

not available RVG 23050 JANSSEN-CILAG BV NL

Sporanox DERM 100 mg Kapseln

not available 1-20781 JANSSEN-CILAG PHARMA

GMBH

AT

SPORANOX 10 mg/ml πόσιμο διάλυμα

not available 39720/10/25.04.2011 JANSSEN-CILAG

PHARMACEUTICAL S.A.C.I.

GR

Sporanox-Pulse not available PL 00242/0334 JANSSEN-CILAG LIMITED UK

Sporanox 100 mg Kapseln not available 1-19236 JANSSEN-CILAG PHARMA GMBH

AT

SPORANOX 100 mg, gélule not available 334 628-8 JANSSEN-CILAG FR

SEMPERA Kapseln, 100 mg Hartkapseln

not available 31040.00.00 JANSSEN-CILAG GMBH DE

Sporanox 100 mg hylki, hörð. not available 920150 JANSSEN-CILAG AB IS

Sporanox 100 mg hårda kapslar

not available 11900 JANSSEN-CILAG AB SE

SPORANOX 100mg Capsules not available PA 0748/009/002 JANSSEN-CILAG LIMITED IE

(6)

SPORANOX® 10 mg/ml peroralna raztopina

not available 5363-I-32/08 JOHNSON & JOHNSON PRODAJA MEDICINSKIH IN FARMACEVTSKIH IZDELKOV, D.O.O.

SI

SPORANOX 100 mg trde kapsule

not available 5363-I-433/10 JOHNSON & JOHNSON PRODAJA MEDICINSKIH IN FARMACEVTSKIH IZDELKOV, D.O.O.

SI

SPORANOX 100 mg trde kapsule

not available 5363-I-365/12 JOHNSON & JOHNSON PRODAJA MEDICINSKIH IN FARMACEVTSKIH IZDELKOV, D.O.O.

SI

SPORANOX 100 MG καψάκια σκληρά

not available 39717/10/25.4.2011 JANSSEN-CILAG

PHARMACEUTICAL S.A.C.I.

GR

SPORANOX 100 mg trde kapsule

not available 5363-I-434/10 JOHNSON & JOHNSON PRODAJA MEDICINSKIH IN FARMACEVTSKIH IZDELKOV, D.O.O.

SI

Sporanox 100 mg cápsulas not available 8722330 JANSSEN FARMACÊUTICA PORTUGAL, LDA

PT

Sporanox 100 mg cápsulas not available 8722322 JANSSEN FARMACÊUTICA PORTUGAL, LDA

PT

Sporanox 100 mg cápsulas not available 8722306 JANSSEN FARMACÊUTICA PORTUGAL, LDA

PT

Sporanox 100 mg cápsulas not available 8722314 JANSSEN FARMACÊUTICA PORTUGAL, LDA

PT

Sporanox 100 mg kapseli, kova not available 11191 JANSSEN-CILAG OY FI

(7)

List of nationally authorised medicinal products

EMA/817337/2017 Page 7/8

Product Name

(in authorisation country)

MRP/DCP Authorisation Number

National Authorisation Number

MAH of product in the Member State

Member State where product is authorised

SPORANOX 100 mg cápsulas not available 59.343 JANSSEN-CILAG S.A. ES

Orungal 100 mg capsule not available 4909/2004/03 JANSSEN PHARMACEUTICA NV RO Orungal 100 mg capsule not available 4909/2004/01 JANSSEN PHARMACEUTICA NV RO

Micogal 100 mg capsule not available 7080/2014/01 S.C. ROMPHARM COMPANY S.R.L.

RO

SPORANOX IV 10 mg/ml concentrato e solvente, soluzione per infusione

UK/H/0158/002 027808031/M JANSSEN-CILAG SPA IT

Sempera 10 mg/ml Konzentrat und Lösungsmittel zur

Herstellung einer Infusionslösung

UK/H/0158/002 54832.00.00 JANSSEN-CILAG GMBH DE

Sporanox IV 10 mg/ml concentrate and solvent for solution for infusion.

UK/H/0158/002 PL 00242/0344 JANSSEN-CILAG LIMITED UK

SPORANOX IV 10 mg/ml concentrate and solvent for solution for infusion.

UK/H/0158/002 PA 748/9/4 JANSSEN-CILAG LIMITED IE

SPORANOX I.V. 10 mg/ml πυκνό διάλυμα και διαλύτης για παρασκευή διαλύματος προς έγχυση

UK/H/0158/002 8081 JANSSEN-CILAG

PHARMACEUTICAL S.A.C.I.

GR

SPORANOX IV 10 mg/ml, concentrado e solvente para solução para perfusão.

UK/H/0158/002 4259883 JANSSEN FARMACÊUTICA

PORTUGAL, LDA

PT

(8)

ITRAGERM 50 mg cápsulas duras

UK/H/4345/001 77459 MAYNE PHARMA UK LIMITED ES

ITRAISDIN 50 mg Hartkapseln UK/H/4345/001 83943.00.00 ISDIN GMBH DE

Mytra 50 mg Hartkapseln UK/H/4345/001 137209 A-MED GMBH AT

LOZANOC 50 mg hard capsules UK/H/4345/01/DC PL 37190/0001 MAYNE PHARMA UK LIMITED UK

CANADIOL 10 mg/ml solución oral

not available 61.864 LABORATORIOS DR. ESTEVE

S.A.

ES

CANADIOL 100 mg cápsulas not available 59.371 LABORATORIOS DR. ESTEVE S.A.

ES

CANADIOL 10 mg/ml solución oral

not available 61.864 LABORATORIOS DR. ESTEVE

S.A.

ES

CANADIOL 100 mg cápsulas not available 59.371 LABORATORIOS DR. ESTEVE S.A.

ES

CANADIOL 10 mg/ml solución oral

not available 61.864 LABORATORIOS DR. ESTEVE

S.A.

ES

CANADIOL 100 mg cápsulas not available 59.371 LABORATORIOS DR. ESTEVE S.A.

ES

TRIASPORIN 100 mg capsule rigide

not available 027814019 ITALFARMACO S.P.A IT

TRIASPORIN 10 mg/ml soluzione orale

not available 027814021 ITALFARMACO S.P.A IT

Hongoseril 100 mg cápsulas not available 59.591 ISDIN, S.A. ES

Referenzen

ÄHNLICHE DOKUMENTE

Figure 9.1. Breakdowns of the water network in areas with first surface deformation class in 2004-2009. Failure occurrences in 2008 and 2009 are given, in single figures..

It involves a year-long policy coordination cycle featuring scrutiny of national budgets and economic policies, as well as the European Commission issuing reform agendas for each

Pursuant to Article 107b of Directive 2001/83/EC, the Marketing Authorisation Holder(s) for nationally authorised medicinal products (for details see PRAC PSUR assessment

- Reducing fuel consumption and emissions of road transport with National Intelligent Transport Systems Strategy Document (2014-2023) and its Action Plan (2014-2016) -

The units of analysis in the case studies include: sense of community as experience, the significance and outcomes in relationship to well-being, and service design principles to

Mudd Building, 250 Longwood Avenue, Boston, MA 02115, United States of America Department of Medicine, Division of Infectious Diseases, George Washington University Medical Center,

Der grosse Johnson Die Enzyklopädie der Weine, Weinbaugebiete und Weinerzeuger der beiden Autoren Hugh Johnson und Stephen Brook umfasst

Slipeinlagen produzierte. Penaten®, bebe® und Neutrogena® ergänzten in den 1980er- und 1990er-Jahren das Portfolio. Bis Ende 2008 inte- grierte das Unternehmen die McNeil GmbH &